Nathan E Lewis

Title: Nathan E Lewis: Innovator in Protein Expression and Glycosylation Prediction

Introduction

Nathan E Lewis is a prominent inventor based in San Diego, CA, known for his contributions to the fields of protein expression and glycosylation prediction. With a total of 3 patents, his work has significantly advanced the understanding and application of biopharmaceutical production.

Latest Patents

Among his latest patents is the "Asparaginase based selection system for heterologous protein expression in mammalian cells." This invention involves a non-naturally occurring cell that comprises an inoperative genomic asparaginase (Aspg) gene and an inoperative glutamine synthetase (Gs) gene. The cell has been transfected with controllably expressed genes encoding enzymes with asparaginase and glutamine synthetase activities, as well as a heterologous protein of interest. Another notable patent is "Systems and methods for predicting glycosylation on proteins." This technology provides a computational prediction model that includes a novel algorithm for predicting glycosylation and optimizing biopharmaceutical production of therapeutically relevant proteins.

Career Highlights

Nathan has worked with esteemed institutions such as the University of California and the Technical University of Denmark. His innovative research has positioned him as a key figure in the biopharmaceutical industry.

Collaborations

Nathan has collaborated with notable professionals in his field, including Hooman Hefzi and Philipp N Spahn. Their combined expertise has contributed to the advancement of biotechnological applications.

Conclusion

Nathan E Lewis continues to make significant strides in the realm of protein expression and glycosylation prediction. His innovative patents and collaborations reflect his commitment to advancing biopharmaceutical technologies.